Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer

Anticancer Res. 1995 Sep-Oct;15(5B):2301-2.

Abstract

PCNA (proliferating cell nuclear antigen) is a cell cycle related protein that is maximally elevated in late G1 and S-phase of proliferating cells. 114 biopsy specimens of colorectal cancer were immunolabeled with PC 10 which specifically recognizes PCNA; Dukes' staging and histological grading were estimated for each case. All patients were followed-up for at least 60 months or to death. All data were analysed by the computer program NCSS (Number Cruncher Statistical System). According to the results, PCNA-index may be considered an independent prognostic factor for colorectal cancer; it may also be helpful in supporting the therapeutic strategies based only on Dukes' stage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology*
  • Humans
  • Neoplasm Staging
  • Prognosis
  • Proliferating Cell Nuclear Antigen / analysis*
  • Survival Rate

Substances

  • Proliferating Cell Nuclear Antigen